{"id":"https://openalex.org/W2950156367","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.tps658","title":"MotHER: A registry for women with breast cancer who received trastuzumab (T) with or without pertuzumab (P) during pregnancy or within 6 months prior to conception.","display_name":"MotHER: A registry for women with breast cancer who received trastuzumab (T) with or without pertuzumab (P) during pregnancy or within 6 months prior to conception.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2950156367","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.tps658","mag":"2950156367"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.tps658","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.tps658","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.tps658","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068665036","display_name":"Vikki Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096079","display_name":"INC Research (United States)","ror":"https://ror.org/00qytmr47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vikki Brown","raw_affiliation_strings":["INC Research, Raleigh, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INC Research, Raleigh, NC","institution_ids":["https://openalex.org/I4210096079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039694693","display_name":"Ann H. Partridge","orcid":"https://orcid.org/0000-0002-4722-4824","observed_orcids":["https://orcid.org/0000-0002-4722-4824"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann Partridge","raw_affiliation_strings":["Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047843312","display_name":"Laura Kay Chu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Chu","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053167365","display_name":"Tania Szado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tania Szado","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074495209","display_name":"Caroline Trudeau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caroline Trudeau","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101878447","display_name":"Elizabeth B. Andrews","orcid":"https://orcid.org/0000-0003-1131-5983","observed_orcids":["https://orcid.org/0000-0003-1131-5983"]},"institutions":[{"id":"https://openalex.org/I180297670","display_name":"RTI International","ror":"https://ror.org/052tfza37","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth B Andrews","raw_affiliation_strings":["RTI International, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI International, Research Triangle Park, NC","institution_ids":["https://openalex.org/I180297670"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"TPS658","last_page":"TPS658"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pregnancy","display_name":"pregnancy","score":0.6620000004768372},{"id":"https://openalex.org/keywords/pregnancy-outcomes","display_name":"pregnancy outcomes","score":0.4320000112056732},{"id":"https://openalex.org/keywords/oligohydramnios","display_name":"oligohydramnios","score":0.9070000052452087},{"id":"https://openalex.org/keywords/congenital-malformations","display_name":"congenital malformations","score":0.8349999785423279},{"id":"https://openalex.org/keywords/fetal-growth-abnormalities","display_name":"fetal growth disorders","score":0.6029999852180481},{"id":"https://openalex.org/keywords/preterm-birth","display_name":"preterm birth","score":0.6830000281333923},{"id":"https://openalex.org/keywords/miscarriage","display_name":"miscarriage","score":0.7039999961853027},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.45899999141693115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9204725027084351},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.7993797659873962},{"id":"https://openalex.org/C131872663","wikidata":"https://www.wikidata.org/wiki/Q5284418","display_name":"Obstetrics","level":1,"score":0.5442883372306824},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.5343384742736816},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.46108266711235046},{"id":"https://openalex.org/C2778279030","wikidata":"https://www.wikidata.org/wiki/Q1543380","display_name":"Live birth","level":3,"score":0.42268848419189453},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33810657262802124},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33470964431762695},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.2696254253387451},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2084699273109436},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.tps658","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.tps658","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.tps658","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1539836902","https://openalex.org/W2314750717","https://openalex.org/W2328472023","https://openalex.org/W3132349342","https://openalex.org/W2035485233","https://openalex.org/W2804118387","https://openalex.org/W1856541499","https://openalex.org/W1981566409","https://openalex.org/W2156695044","https://openalex.org/W2891881749"],"abstract_inverted_index":{"TPS658":[0],"Background:":[1],"T":[2,13,31,46,95],"and":[3,20,49,70,75,152,229,240,254,261,288],"P":[4,25,100],"are":[5,58,153,159,305],"monoclonal":[6],"antibodies":[7,57],"that":[8],"target":[9],"different":[10],"HER2":[11],"epitopes.":[12],"is":[14,26,112,130,169,188,259,301],"approved":[15,27],"for":[16,32,216,263,285,293],"treatment":[17],"of":[18,65,94,117,120,135,165,231,298,318],"early":[19],"metastatic":[21],"HER2+":[22,35],"BC":[23],"while":[24],"in":[28,41,51,83,103,109,278,320],"combination":[29],"with":[30,204,269],"previously":[33],"untreated":[34],"MBC.":[36],"Oligohydramnios":[37],"has":[38],"been":[39],"reported":[40],"patients":[42],"(pts)":[43],"who":[44],"received":[45],"during":[47,140,184],"pregnancy,":[48],"also":[50],"P-treated":[52],"pregnant":[53],"monkeys.":[54],"Although":[55],"both":[56],"FDA":[59,87],"Pregnancy":[60],"Category":[61],"D,":[62],"indicating":[63],"evidence":[64],"fetal":[66,251],"harm,":[67],"some":[68],"physicians":[69,304],"pts":[71,219,287,300],"accept":[72],"this":[73],"risk":[74],"continue":[76],"treatment.":[77],"The":[78,257,274,296],"MotHER":[79,111,129],"registry":[80,133,275],"was":[81,101],"established":[82],"2008":[84],"as":[85,223],"an":[86],"postmarketing":[88],"commitment":[89],"to":[90,138,147,212,283,291,307,312],"evaluate":[91],"the":[92,104,113,118,162,185,214,279,316],"effects":[93,119],"therapy":[96,124],"on":[97,125,176],"pregnancy":[98,126,141,156,201,232,236],"outcome;":[99,157],"included":[102],"study":[105,116,134,258],"following":[106],"its":[107],"approval":[108],"2012.":[110],"first":[114,163],"prospective":[115],"a":[121,131,191,224],"targeted":[122],"cancer":[123],"outcome.":[127,202],"Methods:":[128],"US":[132,280],"women":[136],"exposed":[137],"T\u00b1P":[139,319],"or":[142,183],"within":[143],"6":[144],"months":[145],"prior":[146],"conception.":[148],"Women":[149],"enroll":[150],"voluntarily":[151],"followed":[154,160],"until":[155],"infants":[158],"through":[161],"year":[164],"life.":[166],"Medical":[167],"information":[168],"primarily":[170],"collected":[171],"from":[172,281,289],"healthcare":[173],"providers.":[174],"Information":[175],"potential":[177,215,299],"birth":[178,182,192],"defects":[179],"noted":[180],"at":[181],"pediatric":[186],"follow-up":[187],"classified":[189],"by":[190],"defect":[193],"evaluator/clinical":[194],"geneticist.":[195],"Enrollment":[196],"must":[197],"be":[198,221,272],"initiated":[199],"before":[200],"Pts":[203],"known":[205],"prenatal":[206],"testing":[207],"results":[208],"may":[209],"enroll,":[210],"but":[211],"reduce":[213],"bias":[217],"these":[218],"will":[220,271,276],"analyzed":[222],"subset.":[225],"Primary":[226],"outcomes:":[227,245],"number":[228,297],"nature":[230],"complications,":[233],"including":[234],"oligohydramnios,":[235],"outcomes,":[237],"fetal/infant":[238,241],"outcomes":[239],"functional":[242],"deficits.":[243],"Secondary":[244],"preterm":[246],"births,":[247],"elective/therapeutic":[248],"abortions,":[249],"miscarriages,":[250],"growth":[252],"abnormalities":[253],"delivery":[255],"complications.":[256],"descriptive":[260],"not":[262],"formal":[264],"hypothesis":[265],"testing;":[266],"event":[267],"proportions":[268],"CIs":[270],"calculated.":[273],"accrue":[277],"2009":[282],"2019":[284],"T-treated":[286],"2012":[290],"2022":[292],"P+T-treated":[294],"pts.":[295],"small":[302],"therefore":[303],"encouraged":[306],"refer":[308],"any":[309],"eligible":[310],"pt":[311],"increase":[313],"knowledge":[314],"about":[315],"safety":[317],"pregnancy.":[321],"herceptinpregnancyregistry.com.":[322],"Clinical":[323],"trial":[324],"information:":[325],"NCT00833963.":[326]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2019-06-27T00:00:00"}